| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.2 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |